^
1m
DECIST: Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma (clinicaltrials.gov)
P1, N=43, Active, not recruiting, Baylor College of Medicine | Recruiting --> Active, not recruiting
Enrollment closed
|
CD4 (CD4 Molecule)
|
DOC1021
10ms
Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma (clinicaltrials.gov)
P1, N=17, Completed, The Cooper Health System | Recruiting --> Completed | Trial completion date: Dec 2025 --> Dec 2023 | Trial primary completion date: Dec 2022 --> Dec 2023
Trial completion • Trial completion date • Trial primary completion date • Combination therapy
|
DOC1021
11ms
Trial completion date • Trial primary completion date • Combination therapy
|
CD4 (CD4 Molecule)
|
DOC1021